Format

Send to

Choose Destination
Clin Genitourin Cancer. 2017 Feb;15(1):e145-e150. doi: 10.1016/j.clgc.2016.05.019. Epub 2016 May 27.

Molecular Dissection of Complete Response to Receptor Tyrosine Kinase Inhibition in Type II Papillary Renal Cell Carcinoma.

Author information

1
Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Institute of Biosciences and Medical Technology, Tampere, Finland.
2
Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
3
School of Clinical Sciences, Monash University, Melbourne, Australia.
4
Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
5
Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: awyatt@prostatecentre.com.

KEYWORDS:

DNA damage repair; Fumarate hydratase; Hereditary leiomyomatosis and renal cell cancer; Pazopanib; Sunitinib

PMID:
27324055
DOI:
10.1016/j.clgc.2016.05.019
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center